title: Differentially expressed genes in androgen-dependent and -independent prostate carcinomas.
abstract: Differential gene expression between androgen-dependent (LNCaP-FGC) and androgen-independent (LNCaP-LNO) prostate cancer cells has been investigated using RNA arbitrarily primed and differential display PCR of mRNA. Four differentially expressed cDNA transcripts were identified, of which differential expression was confirmed by Northern blot analysis. Sequence analysis revealed two unknown (JC19 and GC79) and two known genes [B-cell translocation gene 1 and UDP-glucuronosyltransferase 2B15 (UGT2B15)]. JC19, GC79, and B-cell translocation gene 1 were more highly expressed in LNCaP-FGC cells compared with LNCaP-LNO cells, whereas UGT2B15 was only expressed in LNCaP-LNO cells. Androgens and 1,25-dihydroxyvitamin D3 were able to down-regulate UGT2B15 mRNA in LNCaP-LNO cells. For GC79 mRNA, down-regulation was only observed with androgens in LNCaP-FGC cells. Expression of JC19 mRNA was studied using a panel of human prostate cancer xenografts. In androgen-dependent xenografts, expression of JC19 mRNA was much higher compared with androgen-independent xenografts, in which significant expression was hardly detectable. The mRNA expression pattern in the xenografts is in good agreement with that observed in the cell culture system. In conclusion, the differential display technique used in the present study allows analysis of gene expression in vitro and in vivo and can be used for the identification of important genes involved in androgen-independent prostate cancer development.
authors.affiliation: Department of Endocrinology and Reproduction, Erasmus University Rotterdam, the Netherlands. chang@endov.fgg.eur.nl
authors.forename: G T
authors.initials: GT
authors.lastname: Chang
authors.forename: L J
authors.initials: LJ
authors.lastname: Blok
authors.forename: M
authors.initials: M
authors.lastname: Steenbeek
authors.forename: J
authors.initials: J
authors.lastname: Veldscholte
authors.forename: W M
authors.initials: WM
authors.lastname: van Weerden
authors.forename: G J
authors.initials: GJ
authors.lastname: van Steenbrugge
authors.forename: A O
authors.initials: AO
authors.lastname: Brinkmann
mesh_terms: D000728:Androgens / Q000502:physiology*; D000818:Animals; D001483:Base Sequence; D002117:Calcitriol / Q000494:pharmacology; D002453:Cell Cycle; D002455:Cell Division / Q000187:drug effects; D003001:Cloning, Molecular; D004268:DNA-Binding Proteins; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D014453:Glucuronosyltransferase / Q000235:genetics*; D006801:Humans; D008297:Male; D015741:Metribolone / Q000494:pharmacology; D051379:Mice; D008819:Mice, Nude; D008969:Molecular Sequence Data; D009363:Neoplasm Proteins / Q000235:genetics*; D009368:Neoplasm Transplantation; D011471:Prostatic Neoplasms / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics; D012334:RNA, Neoplasm / Q000235:genetics; D012097:Repressor Proteins; D014157:Transcription Factors; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured
chemical_list: D000728:Androgens; C489552:Btg1 protein, mouse; D004268:DNA-Binding Proteins; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D012097:Repressor Proteins; C108387:TRPS1 protein, human; D014157:Transcription Factors; C074086:BTG1 protein, human; D015741:Metribolone; D014453:Glucuronosyltransferase; D002117:Calcitriol